IRVINE, Calif., Aug. 23, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that veteran sales and diagnostic executive Mark McDonough has been named Chief Commercial Officer, effective immediately. McDonough, 43, will report directly to CombiMatrix CEO R. Judd Jessup.
McDonough, a resident of San Diego, has more than 20 years of sales experience and business development with a specialty in diagnostics. He has experience working in a variety of business environments, including start-ups, emerging companies, and large Fortune 500 companies including EMC and Lab Corp.
"Mark has shown that he can build and lead a sales team, and craft a successful commercial strategy, which is critical as we continue to take advantage of the positive momentum we have built in our pre-natal and pediatric businesses," Jessup said. "2012 has ushered in important clinical and commercial catalysts that have led CombiMatrix to shift its focus, and we are now redeploying our selling organization squarely on the developmental markets, where we believe we have a greater opportunity for growth."Jessup concluded, "We believe we have already made solid progress in redeploying our resources in the past few months as we seek to take advantage of our unique position in the developmental segment. Mark's leadership will be instrumental in helping us further optimize the organization and approach as we move those efforts forward. We are very pleased to have an executive of Mark's caliber join our team." McDonough was most recently Vice President, Sales, Customer Service and Training at Redwood City, CA-based Pathwork Diagnostics, a position he held since 2008. He demonstrated the ability to grow sales each year, served on the executive steering committee and was actively involved in all strategic commercial initiatives. Prior to that, from 2002-2008, McDonough worked for Irvine, CA-based USLabs/Dianon (when USLabs was acquired by LabCorp) and ultimately became Vice President of Sales. During his time there, he led a 56-member sales team, led various sales and marketing initiatives and helped drive a turnaround effort during a management overhaul.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV